BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 335137)

  • 1. [Urinary and serum fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
    Akiyama T; Kaneko S; Iguchi M; Minami K; Kadowaki T
    Nihon Hinyokika Gakkai Zasshi; 1977 Jun; 68(6):599-608. PubMed ID: 335137
    [No Abstract]   [Full Text] [Related]  

  • 2. [Qualitative analysis of urinary fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
    Akiyama T
    Nihon Hinyokika Gakkai Zasshi; 1978 Nov; 69(11):1391-403. PubMed ID: 368396
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of fibrinuria with fibrinogen split-product E following kidney allotransplantation.
    Zühlke V; Hölscher M; Reichel W; Pernice G
    Contrib Nephrol; 1975; 1():103-8. PubMed ID: 797519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of fibrin/fibrinogen degradation products in primary glomerular disease (author's transl)].
    Kazuta Y
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):383-95. PubMed ID: 671857
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of formation and diagnostic value of fibrin fibrinogen split products in kidney allotransplantation].
    Drannik GN
    Urol Nefrol (Mosk); 1979; (2):62-9. PubMed ID: 375530
    [No Abstract]   [Full Text] [Related]  

  • 6. [Excretion of the fibrin-fibrinogen degradation products as a sign of rejection of transplanted kidney].
    Belitskaia GA; Ena IaM; Drannik GN; Varetskaia TV; Tsynkalovskaia SN
    Urol Nefrol (Mosk); 1976; (5):52-5. PubMed ID: 793136
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The determination of fibrinolytic degradation products in concentrated urine after renal transplantation.
    Ekberg M; Bergentz SE; Hedner U; Nilsson IM
    Scand J Urol Nephrol; 1976; 10(1):56-62. PubMed ID: 775625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic degradation products in urine of anticoagulated transplant patients.
    Aguilo JJ; Bowie EJ; Woods JE; Owen CA
    Eur Urol; 1978; 4(1):46-9. PubMed ID: 342250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
    Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
    Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrin fibrinogen degradation products in the urine of patients with kidney transplantations].
    Leithner C; Oppolzer R; Wolf A; Pinggera W; Stummvoll HK
    Wien Med Wochenschr; 1975 Oct; 125(41):598-9. PubMed ID: 775807
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary excretion of factor-VIII-related antigen and fibrin(ogen) degradation fragments D and E after kidney transplantation.
    Ponticelli C; Ruggeri ZM; Gordon YB; Ardaillou N; Larrieu MJ; Tarantino A; Coppola R; Mannucci PM
    Transplant Proc; 1979 Mar; 11(1):448-51. PubMed ID: 377673
    [No Abstract]   [Full Text] [Related]  

  • 13. Radio-fibrinogen catabolism and fibrin products for the assessment of renal disease.
    Wardle EN
    Nephron; 1977; 18(4):193-200. PubMed ID: 323738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum and urinary fibrin/fibrinogen degradation products (FDP) in patients with urologic malignancies (author's transl)].
    Ohtaki M
    Nihon Hinyokika Gakkai Zasshi; 1977 Dec; 68(12):1172-83. PubMed ID: 609173
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimum steriod requirements in renal transplant patients monitored by urinary fibrin degradation products and complement.
    Anderton JL; Fananapazir L; Eccleston M
    Proc Eur Dial Transplant Assoc; 1977; 14():342-50. PubMed ID: 341136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
    Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN
    Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
    [No Abstract]   [Full Text] [Related]  

  • 17. [The detection of serum and urine fibrin and fibrinogen degradation products by hemagglutination inhibition test (author's transl)].
    Wang Z
    Zhonghua Nei Ke Za Zhi; 1979; 18(5):330-3. PubMed ID: 555935
    [No Abstract]   [Full Text] [Related]  

  • 18. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
    Cattran DC; Hockley M; Fenton SS; Wilson DR
    Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of NAG and FDP in acute renal graft rejection.
    Garcia B; Thompson AE; Tucker SM; Wing AJ
    Proc Eur Dial Transplant Assoc; 1975; 11():311-9. PubMed ID: 1105552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of urinary fibrin/fibrinogen degradation products by radioimmunoassay.
    Ekberg M; Hedner U; Larsson I; Nilsson IM; Nosslin B
    Scand J Clin Lab Invest; 1976 Sep; 36(5):453-9. PubMed ID: 790536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.